{
    "Trade/Device Name(s)": [
        "ARKTM Lamotrigine Assay",
        "ARKTM Lamotrigine Calibrator",
        "ARKTM Lamotrigine Control"
    ],
    "Submitter Information": "ARK Diagnostics, Inc.",
    "510(k) Number": "K101305",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062966"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "ORH",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "October 28, 2010",
    "Summary Letter Received Date": "October 29, 2010",
    "Submission Date": "October 20, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.3350",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Diphenylhydantoin Test System"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "tdm"
    ],
    "Analyte(s)": [
        "Lamotrigine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARK Lamotrigine Assay, Calibrator, and Control for quantitative lamotrigine measurement in serum or plasma using homogeneous enzyme immunoassay.",
    "Indications for Use Summary": "Quantitative determination of lamotrigine in human serum or plasma on automated clinical chemistry analyzers to aid in management of patients treated with lamotrigine; calibrators and controls are for calibration and quality control of the assay.",
    "fda_folder": "Toxicology"
}